TFF2 and esophageal cancer: Similarly, Papineni et al demonstrated that Tolfenamic acid inhibits esophageal cancer through repression of Sp proteins and several Sp-dependent genes and proteins such as VEGF, survivin, cyclin D1 and Bcl-2 [47].